QingSong Health Corporation (HKG:2661)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
67.95
+0.95 (1.42%)
Last updated: Dec 31, 2025, 11:11 AM HKT

QingSong Health Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
1,246945.01489.96393.61
Revenue Growth (YoY)
216.54%92.87%24.48%-
Cost of Revenue
846.44583.3898.4968.44
Gross Profit
399.48361.63391.48325.16
Selling, General & Admin
257.45227.04187.1125.61
Research & Development
74.6172.0461.3952.82
Other Operating Expenses
3.033.03--
Operating Expenses
334.95302.15248.78178.62
Operating Income
64.5259.48142.7146.54
Interest & Investment Income
810.879.078.44
Currency Exchange Gain (Loss)
0.05-1.83-2.39-10.01
Other Non Operating Income (Expenses)
-18.75-11.1607
EBT Excluding Unusual Items
53.8357.36149.38151.97
Gain (Loss) on Sale of Investments
0.290.123.55
Gain (Loss) on Sale of Assets
-0.28-0.05-
Other Unusual Items
28.93-50.37-48.3-150.63
Pretax Income
83.047.38104.546.34
Income Tax Expense
2.59-1.617.3715.44
Earnings From Continuing Operations
80.458.9997.17-9.1
Earnings From Discontinued Operations
-1.41-23.527.04
Net Income
80.4510.473.65-2.06
Net Income to Common
80.4510.473.65-2.06
Net Income Growth
--85.88%--
Shares Outstanding (Basic)
80808080
Shares Outstanding (Diluted)
15210120280
Shares Change (YoY)
89.62%-50.09%152.68%-
EPS (Basic)
1.000.130.92-0.03
EPS (Diluted)
0.210.110.60-0.03
EPS Growth
--81.09%--
Free Cash Flow
89.7182.797.6557.2
Free Cash Flow Per Share
0.590.820.040.71
Gross Margin
32.06%38.27%79.90%82.61%
Operating Margin
5.18%6.29%29.13%37.23%
Profit Margin
6.46%1.10%15.03%-0.52%
Free Cash Flow Margin
7.20%8.76%1.56%14.53%
EBITDA
64.8559.7142.99146.99
EBITDA Margin
5.21%6.32%29.18%37.34%
D&A For EBITDA
0.330.230.290.45
EBIT
64.5259.48142.7146.54
EBIT Margin
5.18%6.29%29.13%37.23%
Effective Tax Rate
3.12%-7.05%243.52%
Advertising Expenses
-129.31107.0448.15
Source: S&P Global Market Intelligence. Standard template. Financial Sources.